JP2010539107A5 - - Google Patents

Download PDF

Info

Publication number
JP2010539107A5
JP2010539107A5 JP2010524335A JP2010524335A JP2010539107A5 JP 2010539107 A5 JP2010539107 A5 JP 2010539107A5 JP 2010524335 A JP2010524335 A JP 2010524335A JP 2010524335 A JP2010524335 A JP 2010524335A JP 2010539107 A5 JP2010539107 A5 JP 2010539107A5
Authority
JP
Japan
Prior art keywords
solution
composition
neuregulin
organ
storage
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010524335A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010539107A (ja
JP5421916B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CN2008/001610 external-priority patent/WO2009033373A1/en
Publication of JP2010539107A publication Critical patent/JP2010539107A/ja
Publication of JP2010539107A5 publication Critical patent/JP2010539107A5/ja
Application granted granted Critical
Publication of JP5421916B2 publication Critical patent/JP5421916B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2010524335A 2007-09-12 2008-09-12 臓器保存のためのニューレグリンの使用 Active JP5421916B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US99356607P 2007-09-12 2007-09-12
US60/993,566 2007-09-12
PCT/CN2008/001610 WO2009033373A1 (en) 2007-09-12 2008-09-12 Use of neuregulin for organ preservation

Publications (3)

Publication Number Publication Date
JP2010539107A JP2010539107A (ja) 2010-12-16
JP2010539107A5 true JP2010539107A5 (https=) 2011-11-04
JP5421916B2 JP5421916B2 (ja) 2014-02-19

Family

ID=40451568

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010524335A Active JP5421916B2 (ja) 2007-09-12 2008-09-12 臓器保存のためのニューレグリンの使用

Country Status (5)

Country Link
US (2) US20090156488A1 (https=)
EP (2) EP2586305A1 (https=)
JP (1) JP5421916B2 (https=)
CN (1) CN101877961B (https=)
WO (1) WO2009033373A1 (https=)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPP785098A0 (en) 1998-12-21 1999-01-21 Victor Chang Cardiac Research Institute, The Treatment of heart disease
AU2002304965A1 (en) 2002-05-24 2003-12-12 Zensun (Shanghai) Sci-Tech.Ltd Neuregulin based methods and compositions for treating viral myocarditis and dilated cardiomyopathy
ES2530526T3 (es) 2005-12-30 2015-03-03 Zensun Shanghai Science And Technology Ltd Liberación extendida de neurregulina para mejorar la función cardíaca
EP2370458B1 (en) * 2008-11-28 2014-10-15 Zensun (Shanghai) Science and Technology Limited Neuregulin peptides and their use
ES2575125T3 (es) * 2009-06-09 2016-06-24 Zensun (Shanghai) Science And Technology Limited Métodos basados en Neuregulina para el tratamiento de la insuficiencia cardíaca
ES2748886T3 (es) 2009-06-09 2020-03-18 Zensun Shanghai Science & Tech Co Ltd Métodos basados en Neuregulina para el tratamiento de la insuficiencia cardíaca
US20120121557A1 (en) * 2009-07-22 2012-05-17 Children's Medical Center Corporation Neuregulin induced proliferation of cardiomyocytes
JP6096262B2 (ja) 2009-08-25 2017-03-15 ゼンサン （シャンハイ） サイエンス アンド テクノロジー，シーオー．，エルティーディー． ニューレグリンに基づく心不全の治療方法
CN102139095A (zh) * 2010-01-29 2011-08-03 上海泽生科技开发有限公司 神经调节蛋白用于预防、治疗或延迟心脏缺血再灌注损伤的方法和组合物
CN104399062A (zh) * 2011-01-11 2015-03-11 上海泽生科技开发有限公司 神经调节蛋白用于预防、治疗或延迟心脏缺血再灌注损伤的方法和组合物
WO2013053076A1 (en) * 2011-10-10 2013-04-18 Zensun （Shanghai）Science & Technology Limited Compositions and methods for treating heart failure
AU2012392119B2 (en) 2012-10-08 2018-07-26 Zensun (Shanghai) Science & Technology, Co. Ltd. Compositions and methods for treating heart failure in diabetic patients
EP3895724B1 (en) 2013-05-22 2025-06-25 Zensun (Shanghai) Science and Technology, Co., Ltd. Extended release of neuregulin for treating heart failure
CN110946993A (zh) * 2014-01-03 2020-04-03 上海泽生科技开发股份有限公司 纽兰格林制剂的配方
CN105497876B (zh) 2014-09-24 2021-01-15 上海泽生科技开发股份有限公司 神经调节蛋白用于预防、治疗或延迟心脏室性心律失常的方法和组合物
CN111407882A (zh) 2014-10-17 2020-07-14 上海泽生科技开发股份有限公司 神经调节蛋白用于预防、治疗或延迟射血分数保留的心力衰竭的方法和组合物
AR121035A1 (es) 2019-04-01 2022-04-13 Lilly Co Eli Compuestos de neuregulina-4 y métodos de uso
CA3222782A1 (en) 2021-06-10 2022-12-15 Amgen Inc. Engineered nrg-1 variants with improved selectivity toward erbb4 but not against erbb3

Family Cites Families (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3773919A (en) * 1969-10-23 1973-11-20 Du Pont Polylactide-drug mixtures
US4179337A (en) * 1973-07-20 1979-12-18 Davis Frank F Non-immunogenic polypeptides
US4263428A (en) 1978-03-24 1981-04-21 The Regents Of The University Of California Bis-anthracycline nucleic acid function inhibitors and improved method for administering the same
JPS6023084B2 (ja) * 1979-07-11 1985-06-05 味の素株式会社 代用血液
DE3169595D1 (en) 1980-11-10 1985-05-02 Gersonde Klaus Method of preparing lipid vesicles by ultrasonic treatment, the use of this method and apparatus for its application
IE52535B1 (en) 1981-02-16 1987-12-09 Ici Plc Continuous release pharmaceutical compositions
US4485045A (en) * 1981-07-06 1984-11-27 Research Corporation Synthetic phosphatidyl cholines useful in forming liposomes
US4640835A (en) * 1981-10-30 1987-02-03 Nippon Chemiphar Company, Ltd. Plasminogen activator derivatives
JPS58118008A (ja) 1982-01-06 1983-07-13 Nec Corp デ−タ処理装置
DE3374837D1 (en) 1982-02-17 1988-01-21 Ciba Geigy Ag Lipids in the aqueous phase
DE3218121A1 (de) 1982-05-14 1983-11-17 Leskovar, Peter, Dr.-Ing., 8000 München Arzneimittel zur tumorbehandlung
EP0102324A3 (de) 1982-07-29 1984-11-07 Ciba-Geigy Ag Lipide und Tenside in wässriger Phase
US4544545A (en) * 1983-06-20 1985-10-01 Trustees University Of Massachusetts Liposomes containing modified cholesterol for organ targeting
HUT35524A (en) 1983-08-02 1985-07-29 Hoechst Ag Process for preparing pharmaceutical compositions containing regulatory /regulative/ peptides providing for the retarded release of the active substance
DE3483949D1 (de) 1983-09-26 1991-02-21 Udo Dr Med Ehrenfeld Mittel und erzeugnis fuer die diagnose und therapie von tumoren sowie zur behandlung von schwaechen der zelligen und humoralen immunabwehr.
DE3474511D1 (en) 1983-11-01 1988-11-17 Terumo Corp Pharmaceutical composition containing urokinase
US4496689A (en) * 1983-12-27 1985-01-29 Miles Laboratories, Inc. Covalently attached complex of alpha-1-proteinase inhibitor with a water soluble polymer
EP0206448B1 (en) * 1985-06-19 1990-11-14 Ajinomoto Co., Inc. Hemoglobin combined with a poly(alkylene oxide)
US4798824A (en) * 1985-10-03 1989-01-17 Wisconsin Alumni Research Foundation Perfusate for the preservation of organs
US4791192A (en) * 1986-06-26 1988-12-13 Takeda Chemical Industries, Ltd. Chemically modified protein with polyethyleneglycol
US4938961A (en) * 1989-04-28 1990-07-03 Geoffrey Collins Organ preservation solution containing pokyethylene gycol and method of performing cardioplegia
US5530109A (en) * 1991-04-10 1996-06-25 Ludwig Institute For Cancer Research DNA encoding glial mitogenic factors
US5716930A (en) * 1991-04-10 1998-02-10 Ludwig Institute For Cancer Research Glial growth factors
US5834229A (en) * 1991-05-24 1998-11-10 Genentech, Inc. Nucleic acids vectors and host cells encoding and expressing heregulin 2-α
US7037888B1 (en) * 1992-04-03 2006-05-02 Acorda Therapeutics, Inc. Methods for treating muscle diseases and disorders
KR950000167A (ko) 1993-06-24 1995-01-03 다께다 구니오 항-엔도테린 물질의 서방 제제
US5912326A (en) 1995-09-08 1999-06-15 President And Fellows Of Harvard College Cerebellum-derived growth factors
CA2270423C (en) * 1996-10-31 2009-09-15 Mochida Pharmaceutical Co., Ltd. Prophylactic/therapeutic agent
US6054261A (en) * 1998-05-20 2000-04-25 Q-Pharma, Inc. Coenzyme Q10 compositions for organ protection during perfusion
US6045990A (en) * 1998-07-09 2000-04-04 Baust; John M. Inclusion of apoptotic regulators in solutions for cell storage at low temperature
AUPP785098A0 (en) * 1998-12-21 1999-01-21 Victor Chang Cardiac Research Institute, The Treatment of heart disease
US6635249B1 (en) 1999-04-23 2003-10-21 Cenes Pharmaceuticals, Inc. Methods for treating congestive heart failure
AU2001279073B2 (en) * 2000-07-28 2006-08-24 Christopher J. Murphy Transplant media
AU2003218600C1 (en) * 2002-03-26 2009-12-17 Zensun (Shanghai) Science & Technology Co., Ltd. ERBB3 based methods and compositions for treating neoplasms
AU2002304965A1 (en) * 2002-05-24 2003-12-12 Zensun (Shanghai) Sci-Tech.Ltd Neuregulin based methods and compositions for treating viral myocarditis and dilated cardiomyopathy
AU2003237367A1 (en) * 2002-06-03 2003-12-19 Chiron Corporation Use of nrg4, or inhibitors thereof, in the treatment of colon and pancreatic cancer
WO2004060147A2 (en) * 2002-12-31 2004-07-22 The Board Of Trustees Of The University Of Illinois Tissue and organ preservation, protection and resuscitation
US20060160062A1 (en) * 2005-01-14 2006-07-20 Young Lindon H Perfusion and/or preservation solution for organs
US20070141548A1 (en) * 2005-03-11 2007-06-21 Jorg Kohl Organ transplant solutions and method for transplanting organs
US20070054851A1 (en) * 2005-05-27 2007-03-08 Junyu Lin Methods of and compositions for stimulation of glucose uptake into muscle cells and treatment of diseases
US20070213264A1 (en) * 2005-12-02 2007-09-13 Mingdong Zhou Neuregulin variants and methods of screening and using thereof
US20070148628A1 (en) * 2005-12-09 2007-06-28 Philadelphia College Of Osteopathic Medicine Organ preservation and/or perfusion
ES2530526T3 (es) * 2005-12-30 2015-03-03 Zensun Shanghai Science And Technology Ltd Liberación extendida de neurregulina para mejorar la función cardíaca
US9580515B2 (en) * 2006-08-21 2017-02-28 Zensun (Shanghai) Science & Technology, Co., Ltd. Neukinase, a downstream protein of neuregulin
EP2370093A4 (en) * 2008-11-28 2012-08-29 Zensun Shanghai Science And Technology Ltd NEUREGULIN AND CARDIAC STEM CELLS
EP2370458B1 (en) * 2008-11-28 2014-10-15 Zensun (Shanghai) Science and Technology Limited Neuregulin peptides and their use
ES2748886T3 (es) * 2009-06-09 2020-03-18 Zensun Shanghai Science & Tech Co Ltd Métodos basados en Neuregulina para el tratamiento de la insuficiencia cardíaca

Similar Documents

Publication Publication Date Title
JP2010539107A5 (https=)
Guibert et al. Organ preservation: current concepts and new strategies for the next decade
Salleo et al. Starch-to-sugar conversion in wood parenchyma of field-growing Laurus nobilis plants: a component of the signal pathway for embolism repair?
Bruinsma et al. Subzero organ preservation: the dawn of a new ice age?
CN103168836B (zh) 一种含功能性氨基酸的草莓防腐保鲜剂
WO2010096821A3 (en) Method for ice-free cryopreservation of tissue
Kushnarenko et al. Cold acclimation improves regrowth of cryopreserved apple shoot tips
CN101971798A (zh) 人脐带华通氏胶组织块冻存保护液
CN108094405B (zh) 细胞冻存组合物及其应用
CA2549564A1 (en) Tissue preservation media
CN106417251B (zh) 一种高浓度玻璃化液及石斑鱼胚胎超低温冷冻保存方法
WO2010049996A1 (ja) 哺乳動物の臓器の保存方法
Tsutsumi et al. Cardiac transplantation following a 24-h preservation using a perfusion apparatus
CN104255707B (zh) 一种提高大花蕙兰类原球茎保存效果的方法
CN102422869A (zh) 一种河豚鱼的保鲜方法
Yemaneberhan et al. Beyond the icebox: modern strategies in organ preservation for transplantation
CN103719264A (zh) 一种芒果保水杀菌涂膜液及其制备方法
JP6027300B2 (ja) 細胞または臓器の保存液および保存方法
CN103262837B (zh) 一种家畜精液冷冻保护剂及其应用
CN104255711B (zh) 一种提高百合胚性愈伤组织保存效果的方法
Soares et al. Comparison between Perfadex and locally manufactured low-potassium dextran solution for pulmonary preservation in an ex vivo isolated lung perfusion model
JP2006306821A (ja) 細胞・組織の凍結障害防止液及び凍結保存法
Stowe et al. Ten-hour preservation of guinea pig isolated hearts perfused at low flow with air-saturated Lifor solution at 26 C: comparison to ViaSpan solution
CN101326905A (zh) 坛紫菜幼苗的低温冷藏保存方法
JP2010200749A5 (https=)